AVEO PHARMACEUTICALS INC - COM NEW (AVEO)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
10,473,548
Share change
+836,740
Total reported value
$63,315,000
Put/Call ratio
69%
Price per share
$5.77
Number of holders
59
Value change
+$4,627,355
Number of buys
37
Number of sells
20

Institutional Holders of AVEO PHARMACEUTICALS INC - COM NEW (AVEO) as of Q4 2020

As of 31 Dec 2020, AVEO PHARMACEUTICALS INC - COM NEW (AVEO) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,473,548 shares. The largest 10 holders included NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, Sectoral Asset Management Inc, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, Squarepoint Ops LLC, JPMORGAN CHASE & CO, and TWO SIGMA INVESTMENTS, LP. This page lists 59 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.